General Anesthesia Drugs Market, By Molecule Type (Propofol, Sevoflurane, Dexmedetomidine, Desflurane, Remifentanil, Midazolam, Others) and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and

General Anesthesia Drugs Market, By Molecule Type (Propofol, Sevoflurane, Dexmedetomidine, Desflurane, Remifentanil, Midazolam, Others) and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

General anesthetics is one of the major classes of drugs used for general anesthesia. General anesthetics can be administered for a number of medical conditions including but not limited to the following: respiratory problems, such as lung cancer and asthma; cardiac problems, such as congenital heart disease and myocardial infarction; neurological disorders, such as seizures and Parkinson's disease; severe burns and traumatic brain injury. General anesthesia can also be given for cosmetic reasons, such as breast augmentation and nose surgery.
Market Dynamics:
Increasing funding for R&D in anesthetic drugs is expected to propel growth of the general anesthesia drugs market over the forecast period. For instance, in August 2021, researchers at Washington University School of Medicine in St. Louis and the University of Michigan received a US$ 33 million grant from the Patient-Centered Outcomes Research Institute to compare intravenous propofol to inhaled anesthetic drugs to determine which of the common anesthetic drugs offers better patient recovery experiences and improved clinical outcomes.
Product recall is expected to limit growth of the general anesthesia drugs market over the forecast period. For instance, in May 2021, Hospira announced to recall one lot each of the injectable hospital anesthetics bupivacaine HCL and lidocaine HCL due to mislabeling of product.
Key features of the study:
This report provides in-depth analysis of the general anesthesia drugs market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022 - 2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global general anesthesia drugs market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Baxter International Inc., AstraZeneca, AbbVie Inc., B. Braun Melsungen AG, Fresenius SE & Co. KGaA, and Hospira Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global general anesthesia drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global general anesthesia drugs market
Detailed Segmentation:
Global General Anesthesia Drugs Market, By Molecule Type:
Propofol
Sevoflurane
Dexmedetomidine
Desflurane
Remifentanil
Midazolam
Global General Anesthesia Drugs Market, By Region:
North America
By Molecule Type
Propofol
Sevoflurane
Dexmedetomidine
Desflurane
Remifentanil
Midazolam
By Country
U.S.
Canada
Latin America
By Molecule Type
Propofol
Sevoflurane
Dexmedetomidine
Desflurane
Remifentanil
Midazolam
By Country
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Molecule Type
Propofol
Sevoflurane
Dexmedetomidine
Desflurane
Remifentanil
Midazolam
By Country
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Molecule Type
Propofol
Sevoflurane
Dexmedetomidine
Desflurane
Remifentanil
Midazolam
By Country
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Molecule Type
Propofol
Sevoflurane
Dexmedetomidine
Desflurane
Remifentanil
Midazolam
By Country
GCC
Israel
Rest of Middle East
Africa
By Molecule Type
Propofol
Sevoflurane
Dexmedetomidine
Desflurane
Remifentanil
Midazolam
By Country/Region
South Africa
Central Africa
North Africa
Company Profiles
Baxter International Inc.*
Company Highlights
Products Portfolio
Key Highlights
Financial Performance
Strategies
AstraZeneca
AbbVie Inc.
Braun Melsungen AG
Fresenius SE & Co. KGaA
Hospira Inc.
“*” marked represents similar segmentation in other categories in the respective section.